✦ LIBER ✦

Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function

✍ Scribed by T. Forst; G. Michelson; F. Ratter; M. M. Weber; S. Anders; M. Mitry; B. Wilhelm; A. Pfützner

Book ID: 117949808
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 103 KB
Volume: 29
Category: Article
ISSN: 0742-3071
DOI: 10.1111/j.1464-5491.2012.03589.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in glycaemic control β-cell

Improvement in glycaemic control β-cell function over 2 years with sitagliptin as monotherapy or add-on therapy to metformin in patients with type 2 diabetes

✍ Williams-Herman, D.; Seck, T.; Golm, G.; Wang, H.; Johnson, J.; Kaufman, K.D.; G 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 435 KB

Pharmacodynamic characteristics of lixis

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

✍ Kapitza, C.; Forst, T.; Coester, H.-V.; Poitiers, F.; Ruus, P.; Hincelin-Méry, A 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 606 KB

Effect of linagliptin monotherapy on gly

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial

✍ S. Del Prato; A. H. Barnett; H. Huisman; D. Neubacher; H.-J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Effects of a combination of sitagliptin

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients

✍ Giuseppe Derosa; Anna Carbone; Ivano Franzetti; Fabrizio Querci; Elena Fogari; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 692 KB

Post-meal β-cell function predicts the e

Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose

✍ Chen, Po-Hsun; Tsai, Yi-Ting; Wang, Jun-Sing; Lin, Shi-Dou; Lee, Wen-Jane; Su, S 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 234 KB

The effect of glargine versus glimepirid

The effect of glargine versus glimepiride on pancreatic β-cell function in patients with type 2 diabetes uncontrolled on metformin monotherapy: open-label, randomized, controlled study

✍ Moon, Jun Sung; Ha, Kyoung Soo; Yoon, Ji Sung; Lee, Hyoung Woo; Lee, Hyun Chul; 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 303 KB